Organisation paid for research Program year 2024 Source: CMS Open Payments

Quality Research Inc

Neither a doctor nor a teaching hospital

Research payments

$945,937

305 payments

Through program year 2024, Quality Research Inc is reported as receiving $945,937 in research payments, across 305 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$179,939	7
2023	Research	$37,091	16
2022	Research	$20,974	11
2021	Research	$35,245	175
2020	Research	$416,088	61
2019	Research	$256,600	35

Breakdown

Who paid Research payments · program years 2019–2024

Ironwood Pharmaceuticals, Inc $401,804 37 payments
Noven Pharmaceuticals, Inc. $204,941 26 payments
Braintree Laboratories, Inc. $175,008 6 payments
Novo Nordisk AS $123,631 218 payments
GlaxoSmithKline, LLC. $27,478 12 payments
ACADIA Pharmaceuticals Inc $8,000 2 payments
Phathom Pharmaceuticals, Inc. $4,932 1 payment
Pfizer Inc. $144 3 payments

Studies the money was for Research payments · program years 2019–2024

C3718-301 $261,902 16 payments
A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patients with Erosive Esophagitis $175,008 6 payments
McP-103-312 $123,630 11 payments
Ex9536-4388 $123,002 113 payments
A 4-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of Hp-5000 in Subjects With Osteoarthritis Oa of the Knee. $117,481 8 payments
A 4-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of Hp-5000 in Subjects With Osteoarthritis (Oa) of the Knee. $86,731 2 payments
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, DO $27,478 12 payments
McP-103-205 $16,271 10 payments
Acp-044-005 $8,000 2 payments
Nerd-301 $4,932 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.